1Attention-deficit/hyperactivity disorder (ADHD) is widely recognised as one of the most common neurodevelopmental conditions, traditionally understood as a discrete diagnosis. In many clinical settings, the assumption has been binary: a patient either meets diagnostic criteria for ADHD or does not. Yet recent research and clinical commentary increasingly challenge this view, arguing that ADHD should be considered as existing along a continuum. In this dimensional model, traits such as inattention, hyperactivity, and impulsivity are not confined to a minority of patients but are distributed, in varying degrees, across the general population. Those with more extreme levels may meet formal thresholds for diagnosis, while many others live with subthreshold difficulties that still impair daily life. Recognising ADHD as a spectrum rather than a fixed category could fundamentally change how we identify and support individuals at risk.
2A key benefit of this continuum perspective is its potential to reduce the stigma associated with ADHD. Historically, the label has sometimes been viewed as a marker of deficit or pathology, separating those with a diagnosis from those considered “normal.” By contrast, a spectrum framework highlights that attentional traits lie on a gradient shared by everyone. Just as blood pressure or mood varies within populations, so too do levels of attentional regulation and behavioural control. This normalisation can make it easier for individuals to seek help without feeling that they belong to a stigmatised group. Importantly, it can also facilitate earlier intervention, since clinicians may be more willing to provide support before symptoms escalate into severe impairment.
3However, embracing a continuum approach is not without challenges. Some clinicians worry that blurring diagnostic boundaries risks overdiagnosis or medicalisation of natural variation. If every child who fidgets in class or every adult who struggles with deadlines were labelled as having ADHD, treatment resources could be stretched thin and unnecessary prescriptions could rise. Advocates of the dimensional model emphasise that this is not the intent. The threshold for clinical attention should remain tied to functional impairment: support is warranted when symptoms, whether mild or severe, significantly interfere with education, employment, or social relationships. In other words, a continuum model does not imply universal diagnosis but encourages more flexible and context-sensitive assessment.
4The continuum concept also has profound implications for scientific research. Much existing ADHD research compares two sharply defined groups: “ADHD patients” and “controls.” This binary approach assumes a categorical distinction that may not reflect reality. A dimensional framework would instead analyse how varying degrees of inattention or impulsivity correlate with genetic, neurobiological, and environmental factors. This could yield more nuanced findings, revealing patterns that are invisible when participants are grouped only by diagnostic status. For example, imaging studies might show gradual differences in brain connectivity across the spectrum, rather than stark contrasts between groups. Such evidence would help clarify the mechanisms underlying ADHD traits and inform more targeted interventions.
5In practice, a continuum model supports a stepped-care approach to treatment. Rather than reserving interventions solely for those above a diagnostic cutoff, clinicians could offer graded support aligned with symptom severity. Mild cases might benefit from classroom adjustments, coaching in organisational skills, or behavioural therapy. Moderate cases could add structured cognitive training or targeted psychoeducation for families. For those with severe impairment, pharmacological treatments such as stimulants or non-stimulants would still play a central role. Importantly, this model also recognises that symptom levels are dynamic, influenced by age, stress, sleep, and co-existing conditions. Continuous monitoring becomes essential, ensuring that support is adjusted as circumstances change.
6Educational and workplace policy would also need to adapt. Currently, accommodations such as extended exam time, flexible deadlines, or modified learning environments are often reserved for individuals with a formal diagnosis. Under a spectrum framework, more people with subthreshold impairments could become eligible for tailored support. While this could make learning and employment environments more inclusive, it also raises questions about resource allocation. Systems would need safeguards to ensure that those with the greatest need still receive adequate assistance. Policymakers must therefore balance inclusivity with practicality, designing frameworks that neither exclude struggling individuals nor overwhelm limited resources.
7Ultimately, viewing ADHD as a spectrum reframes it not as a fixed disorder but as part of the natural variability of human cognition. This does not diminish the reality of the condition or the suffering it can cause. Rather, it acknowledges that difficulties exist across degrees of severity and that help should be proportionate to need. The authors of the BMJ commentary argue that shifting towards a continuum perspective can reduce stigma, improve early support, enrich research, and inspire more personalised interventions. For clinicians, teachers, policymakers, and families, adopting this lens could mean moving away from rigid categories and towards a more compassionate, flexible, and evidence-based understanding of attention and behaviour across the lifespan.